STAT+: Trump order on drug pricing appears to issue subtle threat to pharma
Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank approvals if drugmakers do not lower prices.
File this under “Lower your price — or else!”
Tucked inside the executive order on drug pricing from President Trump is a sentence that appears to threaten pharmaceutical companies that their medicines may be withdrawn if they do not lower prices.
Specifically, the order issued on Monday contains a provision concerning “most-favored nation” pricing, which would require pharmaceutical companies to charge Americans prices for medicines that are comparable to what people pay in countries that are similar to the U.S.
